Hexafluoroisopropanol decreases liver ischemia–reperfusion injury by downregulation of high mobility group box‐1 protein

Abstract Liver ischemia–reperfusion (IR) injury is associated with poor outcome after liver transplantation and liver resections. Hexafluoroisopropanol (HFIP) is a tri‐fluorinated metabolites of volatile anesthetics and has modulatory effects on inflammation that have been observed mainly in cell cu...

Full description

Bibliographic Details
Main Authors: Agustin Vintimilla Moscoso, Estela Regina Ramos Figueira, Joel Avancini Rocha‐Filho, Martin Urner, Cinthia Lanchotte, Jose Jukemura, Jorge Luiz Saraiva Ximenes, Sergio Carlos Nahas, Luiz Augusto Carneiro D'Albuquerque, Flavio Henrique Ferreira Galvao
Format: Article
Language:English
Published: Wiley 2022-12-01
Series:Pharmacology Research & Perspectives
Subjects:
Online Access:https://doi.org/10.1002/prp2.1027
_version_ 1798005764937220096
author Agustin Vintimilla Moscoso
Estela Regina Ramos Figueira
Joel Avancini Rocha‐Filho
Martin Urner
Cinthia Lanchotte
Jose Jukemura
Jorge Luiz Saraiva Ximenes
Sergio Carlos Nahas
Luiz Augusto Carneiro D'Albuquerque
Flavio Henrique Ferreira Galvao
author_facet Agustin Vintimilla Moscoso
Estela Regina Ramos Figueira
Joel Avancini Rocha‐Filho
Martin Urner
Cinthia Lanchotte
Jose Jukemura
Jorge Luiz Saraiva Ximenes
Sergio Carlos Nahas
Luiz Augusto Carneiro D'Albuquerque
Flavio Henrique Ferreira Galvao
author_sort Agustin Vintimilla Moscoso
collection DOAJ
description Abstract Liver ischemia–reperfusion (IR) injury is associated with poor outcome after liver transplantation and liver resections. Hexafluoroisopropanol (HFIP) is a tri‐fluorinated metabolites of volatile anesthetics and has modulatory effects on inflammation that have been observed mainly in cell culture experiments. In this survey, we investigated the effects of HFIP in a rat model of normothermic hepatic ischemia–reperfusion injury. Twenty‐four male Wistar rats were randomized into three groups: (1) control in which animals were submitted to 30 min of partial liver ischemia with resection of non‐ischemic liver lobes immediate after reperfusion, (2) pre‐ischemia (PI) group in which animals received intravenous HFIP (67 mg/kg) 5 min before liver ischemia, and (3) pre‐reperfusion (PR) group in which animals received intravenous HFIP (67 mg/kg) 5 min before reperfusion. Four hours after reperfusion, all animals were euthanized for sample collection. Aspartate and alanine transaminases, glucose, and high mobility group box‐1 (HMGB‐1) protein concentrations showed a significant decreased, and malondialdehyde was increased in the PR group compared with control and PI groups. Interleukin 6 (IL‐6) was increased in the PI group compared with control and PR groups. IL‐10 and ‐12 were increased in the PR and PI groups, respectively, when compared with the control group. Glucose decreased in the PR when compared with the control group. Post‐conditioning with HFIP led to a decrease in hepatocellular injury and was associated with a downregulation of HMGB‐1. The HFIP resulted in a better control of inflammatory response to ischemia–reperfusion even without causing a reduction in oxidative stress.
first_indexed 2024-04-11T12:44:18Z
format Article
id doaj.art-765ca6ecfcb64b28a2bfd749ceab97ee
institution Directory Open Access Journal
issn 2052-1707
language English
last_indexed 2024-04-11T12:44:18Z
publishDate 2022-12-01
publisher Wiley
record_format Article
series Pharmacology Research & Perspectives
spelling doaj.art-765ca6ecfcb64b28a2bfd749ceab97ee2022-12-22T04:23:24ZengWileyPharmacology Research & Perspectives2052-17072022-12-01106n/an/a10.1002/prp2.1027Hexafluoroisopropanol decreases liver ischemia–reperfusion injury by downregulation of high mobility group box‐1 proteinAgustin Vintimilla Moscoso0Estela Regina Ramos Figueira1Joel Avancini Rocha‐Filho2Martin Urner3Cinthia Lanchotte4Jose Jukemura5Jorge Luiz Saraiva Ximenes6Sergio Carlos Nahas7Luiz Augusto Carneiro D'Albuquerque8Flavio Henrique Ferreira Galvao9Laboratorio de Investigaçao Medica 37, Departamento de Gastroenterologia, Hospital das Clinicas HCFMUSP, Faculdade de Medicina Universidade de Sao Paulo Sao Paulo BrazilLaboratorio de Investigaçao Medica 37, Departamento de Gastroenterologia, Hospital das Clinicas HCFMUSP, Faculdade de Medicina Universidade de Sao Paulo Sao Paulo BrazilLaboratorio de Investigaçao Medica 37, Departamento de Gastroenterologia, Hospital das Clinicas HCFMUSP, Faculdade de Medicina Universidade de Sao Paulo Sao Paulo BrazilDivisao Interdepartamental de Medicina Intensiva Universidade de Toronto Toronto Ontario CanadaLaboratorio de Investigaçao Medica 37, Departamento de Gastroenterologia, Hospital das Clinicas HCFMUSP, Faculdade de Medicina Universidade de Sao Paulo Sao Paulo BrazilLaboratorio de Investigaçao Medica 37, Departamento de Gastroenterologia, Hospital das Clinicas HCFMUSP, Faculdade de Medicina Universidade de Sao Paulo Sao Paulo BrazilLaboratorio de Investigaçao Medica 37, Departamento de Gastroenterologia, Hospital das Clinicas HCFMUSP, Faculdade de Medicina Universidade de Sao Paulo Sao Paulo BrazilDepartamento de Gastroenterologia, Hospital das Clinicas HCFMUSP, Faculdade de Medicina Universidade de Sao Paulo Sao Paulo BrazilLaboratorio de Investigaçao Medica 37, Departamento de Gastroenterologia, Hospital das Clinicas HCFMUSP, Faculdade de Medicina Universidade de Sao Paulo Sao Paulo BrazilLaboratorio de Investigaçao Medica 37, Departamento de Gastroenterologia, Hospital das Clinicas HCFMUSP, Faculdade de Medicina Universidade de Sao Paulo Sao Paulo BrazilAbstract Liver ischemia–reperfusion (IR) injury is associated with poor outcome after liver transplantation and liver resections. Hexafluoroisopropanol (HFIP) is a tri‐fluorinated metabolites of volatile anesthetics and has modulatory effects on inflammation that have been observed mainly in cell culture experiments. In this survey, we investigated the effects of HFIP in a rat model of normothermic hepatic ischemia–reperfusion injury. Twenty‐four male Wistar rats were randomized into three groups: (1) control in which animals were submitted to 30 min of partial liver ischemia with resection of non‐ischemic liver lobes immediate after reperfusion, (2) pre‐ischemia (PI) group in which animals received intravenous HFIP (67 mg/kg) 5 min before liver ischemia, and (3) pre‐reperfusion (PR) group in which animals received intravenous HFIP (67 mg/kg) 5 min before reperfusion. Four hours after reperfusion, all animals were euthanized for sample collection. Aspartate and alanine transaminases, glucose, and high mobility group box‐1 (HMGB‐1) protein concentrations showed a significant decreased, and malondialdehyde was increased in the PR group compared with control and PI groups. Interleukin 6 (IL‐6) was increased in the PI group compared with control and PR groups. IL‐10 and ‐12 were increased in the PR and PI groups, respectively, when compared with the control group. Glucose decreased in the PR when compared with the control group. Post‐conditioning with HFIP led to a decrease in hepatocellular injury and was associated with a downregulation of HMGB‐1. The HFIP resulted in a better control of inflammatory response to ischemia–reperfusion even without causing a reduction in oxidative stress.https://doi.org/10.1002/prp2.1027hexafluoroisopropanolischemiaischemic postconditioningischemic preconditioningliverreperfusion injury
spellingShingle Agustin Vintimilla Moscoso
Estela Regina Ramos Figueira
Joel Avancini Rocha‐Filho
Martin Urner
Cinthia Lanchotte
Jose Jukemura
Jorge Luiz Saraiva Ximenes
Sergio Carlos Nahas
Luiz Augusto Carneiro D'Albuquerque
Flavio Henrique Ferreira Galvao
Hexafluoroisopropanol decreases liver ischemia–reperfusion injury by downregulation of high mobility group box‐1 protein
Pharmacology Research & Perspectives
hexafluoroisopropanol
ischemia
ischemic postconditioning
ischemic preconditioning
liver
reperfusion injury
title Hexafluoroisopropanol decreases liver ischemia–reperfusion injury by downregulation of high mobility group box‐1 protein
title_full Hexafluoroisopropanol decreases liver ischemia–reperfusion injury by downregulation of high mobility group box‐1 protein
title_fullStr Hexafluoroisopropanol decreases liver ischemia–reperfusion injury by downregulation of high mobility group box‐1 protein
title_full_unstemmed Hexafluoroisopropanol decreases liver ischemia–reperfusion injury by downregulation of high mobility group box‐1 protein
title_short Hexafluoroisopropanol decreases liver ischemia–reperfusion injury by downregulation of high mobility group box‐1 protein
title_sort hexafluoroisopropanol decreases liver ischemia reperfusion injury by downregulation of high mobility group box 1 protein
topic hexafluoroisopropanol
ischemia
ischemic postconditioning
ischemic preconditioning
liver
reperfusion injury
url https://doi.org/10.1002/prp2.1027
work_keys_str_mv AT agustinvintimillamoscoso hexafluoroisopropanoldecreasesliverischemiareperfusioninjurybydownregulationofhighmobilitygroupbox1protein
AT estelareginaramosfigueira hexafluoroisopropanoldecreasesliverischemiareperfusioninjurybydownregulationofhighmobilitygroupbox1protein
AT joelavancinirochafilho hexafluoroisopropanoldecreasesliverischemiareperfusioninjurybydownregulationofhighmobilitygroupbox1protein
AT martinurner hexafluoroisopropanoldecreasesliverischemiareperfusioninjurybydownregulationofhighmobilitygroupbox1protein
AT cinthialanchotte hexafluoroisopropanoldecreasesliverischemiareperfusioninjurybydownregulationofhighmobilitygroupbox1protein
AT josejukemura hexafluoroisopropanoldecreasesliverischemiareperfusioninjurybydownregulationofhighmobilitygroupbox1protein
AT jorgeluizsaraivaximenes hexafluoroisopropanoldecreasesliverischemiareperfusioninjurybydownregulationofhighmobilitygroupbox1protein
AT sergiocarlosnahas hexafluoroisopropanoldecreasesliverischemiareperfusioninjurybydownregulationofhighmobilitygroupbox1protein
AT luizaugustocarneirodalbuquerque hexafluoroisopropanoldecreasesliverischemiareperfusioninjurybydownregulationofhighmobilitygroupbox1protein
AT flaviohenriqueferreiragalvao hexafluoroisopropanoldecreasesliverischemiareperfusioninjurybydownregulationofhighmobilitygroupbox1protein